Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...
Add Yahoo as a preferred source to see more of our stories on Google. TikTok users are calling out the social media app after noticing an apparent "glitch" in the algorithm. "TikTok is having major ...
Instagram head Adam Mosseri has offered fresh insight into how the platform ranks posts and distributes content. He shared these details during a recent appearance on the Mixed Signals podcast, where ...
Quantum computers, systems that process information leveraging quantum mechanical effects, could soon outperform classical computers on some complex computational problems. These computers rely on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback